Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mark Smithers

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Plos One|August 11, 2011
Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinomaDerek J Nancarrow, Andrew D Clouston, B Mark Smithers, et al.
Melanoma Research|October 27, 2023
pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanomaSamuel X Tan, Sharene Chong, Casey Rowe, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2010
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trialBryan H Burmeister, Janine M Thomas, Elizabeth A Burmeister, et al.
Cancer Research|June 4, 2008
Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arraysDerek J Nancarrow, Herlina Y Handoko, B Mark Smithers, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2014
BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapyAndrew P Barbour, Yue Hang Tang, Nicola Armour, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2025
Sociodemographic Disparities in Melanoma Stage at Diagnosis: The Role of Socioeconomic Status and Residential LocationDanielle Gavanescu, Annette Dobson, Hansa Sharma, et al.
JAMA Dermatology|May 2, 2019
Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary TumorLena A von Schuckmann, Maria Celia B Hughes, Reza Ghiasvand, et al.
Neurogastroenterology and Motility|December 16, 2025
Disorders of Gut-Brain Interaction (DGBI) Symptoms and Response to Peroral Endoscopic Myotomy in Patients With AchalasiaRonen Ben Jacob, Thomas Fairlie, Nicholas J Talley, et al.
The Journal of Investigative Dermatology|April 7, 2026
Second primary invasive cutaneous melanomas in Queensland over 4 decadesDanny R Youlden, Victoria Atkinson, Mark B Pinkham, et al.
ESMO Open|July 7, 2022
ctDNA as a biomarker of progression in oesophageal adenocarcinomaV F Bonazzi, L G Aoude, S Brosda, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Plos One|August 11, 2011
Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinomaDerek J Nancarrow, Andrew D Clouston, B Mark Smithers, et al.
Melanoma Research|October 27, 2023
pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanomaSamuel X Tan, Sharene Chong, Casey Rowe, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2010
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trialBryan H Burmeister, Janine M Thomas, Elizabeth A Burmeister, et al.
Cancer Research|June 4, 2008
Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arraysDerek J Nancarrow, Herlina Y Handoko, B Mark Smithers, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2014
BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapyAndrew P Barbour, Yue Hang Tang, Nicola Armour, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2025
Sociodemographic Disparities in Melanoma Stage at Diagnosis: The Role of Socioeconomic Status and Residential LocationDanielle Gavanescu, Annette Dobson, Hansa Sharma, et al.
JAMA Dermatology|May 2, 2019
Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary TumorLena A von Schuckmann, Maria Celia B Hughes, Reza Ghiasvand, et al.
Neurogastroenterology and Motility|December 16, 2025
Disorders of Gut-Brain Interaction (DGBI) Symptoms and Response to Peroral Endoscopic Myotomy in Patients With AchalasiaRonen Ben Jacob, Thomas Fairlie, Nicholas J Talley, et al.
The Journal of Investigative Dermatology|April 7, 2026
Second primary invasive cutaneous melanomas in Queensland over 4 decadesDanny R Youlden, Victoria Atkinson, Mark B Pinkham, et al.
ESMO Open|July 7, 2022
ctDNA as a biomarker of progression in oesophageal adenocarcinomaV F Bonazzi, L G Aoude, S Brosda, et al.
Pageof 13